This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Siblings and Succession in the Family Business (HBR Case Study and Commentary)
Miller, Warren D.; Noble, Kent; Gersick, Kelin F.; Ney, Victor; Wolking, Joseph A.Article HBS-98108-ELeadership and People ManagementHow do family businesses handle succession? What happens when siblings compete for the position of CEO? Can nonfamily board members navigate successfully through conflicts among family members? Should they even try? This fictitious case study examines a host of issues with which family businesses regularly grapple. It describes the situation that faces the board of directors of Benson Electric, a rapidly growing family enterprise, upon the unexpe...Starting at €8.20
-
Ghost in the Family Business (HBR Case Study and Commentary)
Miller, Warren D.; Boschwitz, Gerry; Boschwitz, Rudy; Whiteside, Mary F.; Mattos, Joe; Ward, John L.Article HBS-R00308-EEntrepreneurshipMac Monroe had grand plans for Georgia Building Supplies, the company he had started with a friend almost 50 years ago, selling construction materials wholesale to contractors. In the mid-1980s, Mac bought out his disgruntled partner's share of the company and put his oldest son, Mac Monroe IV, at the helm. It was all falling into place. But Mac Four, as his parents called him, died tragically in a car accident. The family and the company never r...Starting at €8.20
-
When the Boss Won't Budge (HBR Case Study and Commentary)
Maruca, Regina Fazio; Milhaven, John M.; Benasutti, Matt; Lipton, Mark; Hatsopoulos, George N.; Beckert, Dorothy; Miller, Warren D.Article HBS-R00106-ELeadership and People ManagementAllerGen, a young biotechnology firm, is heading for trouble, possibly even bankruptcy. The company's one product--a vaccine for people allergic to cats--may never make it to market. And turnover is on the rise, not only because of the vaccine's uncertain future but also because employees are increasingly unhappy working for founder and Chief Scientific Officer Harry Huston. Although Harry is an excellent scientist, he has no business background....Starting at €8.20